Valuation: Astal Laboratories Limited

Market Cap 2.76B 29.25M 25.65M 23.64M 22.13M 41.5M 42.36M 284M 110M 1.36B 110M 107M 4.73B P/E 2024
26.3x
P/E 2025 9.45x
Enterprise Value 2.87B 30.47M 26.72M 24.63M 23.06M 43.24M 44.13M 296M 115M 1.42B 114M 112M 4.93B EV / Sales 2024
1.45x
EV / Sales 2025 1.36x
Free-Float
38.01%
Yield 2024 *
-
Yield 2025 -
1 day+12.92%
1 week+7.84%
Current month+19.42%
1 month+19.13%
3 months+28.44%
6 months-0.73%
Current year+1.54%
1 week 77.11
Extreme 77.11
91.3
1 month 65.45
Extreme 65.45
91.3
Current year 60.45
Extreme 60.45
91.9
1 year 60.45
Extreme 60.45
103.2
3 years 22.41
Extreme 22.41
131.7
5 years 5.41
Extreme 5.41
131.7
10 years 5.41
Extreme 5.41
131.7
Manager TitleAgeSince
Director of Finance/CFO 51 2023-07-14
Compliance Officer 32 2023-04-18
Director TitleAgeSince
Director/Board Member - 2022-09-07
Director/Board Member - 2022-09-07
Director/Board Member - 2022-09-07
Change 5-day change 1-year change 3-year change Capi.($)
+12.92%+7.84%+7.30%+189.91% 40.84M
+7.13%+9.97%+55.80%+160.09% 1,077B
+3.99%+11.50%+67.09%+55.96% 613B
+4.20%+17.03%+38.97%+91.06% 448B
+0.99%+4.85%+28.17%+23.89% 332B
+1.82%+8.19%+40.04%+27.95% 293B
+0.22%+6.75%+31.30%+42.34% 286B
+0.73%+8.53%-27.33%-39.55% 215B
+1.56%+6.14%+29.30%+60.97% 193B
+3.26%+3.33%+15.55%+68.24% 159B
Average +3.68%+7.71%+28.62%+68.08% 361.61B
Weighted average by Cap. +3.85%+8.93%+41.75%+80.17%

Financials

2024 2025
Net sales 237M 2.51M 2.2M 2.03M 1.9M 3.56M 3.63M 24.37M 9.43M 117M 9.42M 9.21M 405M 637M 6.75M 5.92M 5.45M 5.11M 9.57M 9.77M 65.55M 25.36M 315M 25.34M 24.79M 1.09B
Net income 7.85M 83.18K 72.94K 67.23K 62.94K 118K 120K 808K 313K 3.88M 312K 306K 13.45M 89.25M 946K 830K 765K 716K 1.34M 1.37M 9.19M 3.56M 44.11M 3.55M 3.48M 153M
Net Debt -57.64M -611K -536K -494K -462K -867K -885K -5.94M -2.3M -28.49M -2.29M -2.24M -98.79M 115M 1.22M 1.07M 989K 925K 1.74M 1.77M 11.88M 4.6M 57.02M 4.59M 4.49M 198M
Logo Astal Laboratories Limited
Astal Laboratories Limited is an India-based company, which is engaged in the manufacturing and sale of pharmaceutical intermediates and bulk drugs. The Company is engaged in manufacturing fine chemicals, specialty chemicals and pharmaceutical intermediates. The Company’s products include HF Acid (2-Chloro-1,3-Bis (Dimethylamino) Trimethinium Hexafluorophosphate); 4-Methyl Sulphonyl Phenyl Acetic acid, (1R,3R)-methyl 1-(benzo[d][1,3] dioxol-5-yl)- 2,3,4,9-tetrahydro-1 H-pyrido[3,4-b]indole-3- carboxylate hydrochloride; L-Valine methyl ester Hydrochloride (LVMH); L-Valine benzyl ester Hydrochloride; N-[(2-Cyanobiphenyl-4-methyl)- L-Valine methyl ester Hydrochloride; D-Tryptophan Methyl Ester Hydrochloride; Moc-L-valine (N-(Methoxycarbonyl)-L-valine); 2-Ethoxyethyl-4-methylbenzene sulfonate; 2 Piperidin-4-yl-1H-benzoimidazole; Alpha, alpha-Dimethyl Phenyl Acetic Acid (2-Methyl-2-phenylpropionic acid); 2-(4-bromophenyl)-2-methylpropionic acid; Methyl 2,2-dimethylphenylacetate, and others.
Employees
-
Date Price Change Volume
26-06-25 ₹88.19 +12.92% 137,452
26-06-24 ₹78.10 +0.79% 9,030
26-06-23 ₹77.49 -3.98% 24,763
26-06-22 ₹80.70 -1.32% 17,820
26-06-19 ₹81.78 -2.58% 22,681
  1. Stock Market
  2. Stocks
  3. MACINTR Stock